drugset / Trial / NCT00195013

Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy

NCT00195013

Phase 3 Completed 30 enrolled Weill Medical College of Cornell University
RandomizedParallel-groupDouble-blindTreatment

Summary

Patients with breast cancer receiving paclitaxel chemotherapy who have mild symptoms of peripheral neuropathy will receive glutamine or placebo to try and improve symptoms.

Timeline

Start
2003-12
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Glutamine Other / unclassified 10 g Oral